Dr. Oern R. Stuge MD, MBA,

Chairman

Dr. Oern R. Stuge is the founder of ORSCO Life Sciences AG, where he works with several companies from early stage technology, to bigger listed companies such as Mediq NV and Nobel Biocare AG. Dr Stuge serves in different roles from executive chairman, non executive board member to advisor. Prior to founding ORSCO Life Sciences, Dr. Stuge was Senior Vice President and President of Medtronic Inc., where he worked for 12 years in various different positions including Senior Vice-President and President Cardiac Surgery, President EMEA, Latin America, Canada and India, and member of the Executive Committee and Operating Committee. Prior to this, Dr. Oern R. Stuge had gained six years’ experience at Abbott Laboratories, he worked seven years at a Norwegian start-up, where he also served as CEO, and worked six years as a practising physician in Norway. He received his MD degree from the University of Oslo.

Peter Ohnemus,

Vice-Chairman, Founder and CEO

Peter Ohnemus is the majority owner of dacadoo ag. Peter has been involved in high-tech and bio-tech investments over the last 25 years and this had led to four IPO’s and multiple trade sells.

Peter Ohnemus/Network Capital Holding, his private investment firm, is currently invested in high-tech, bio-tech and sustainable energy/infrastructure start-ups. The company has investments in third generation heart valves, organic search software, algorithm-based skills search exchange, real-time financial data for mobile phones, renewal energy trading platform, carbon trading, etc.

Peter co-founded ASSET4, the world’s leading provider of extra-financial information, in 2004, which was sold to Thomson Reuters in November of 2009. Mr. Ohnemus previously held senior executive positions with Sybase, Logic Works, The Fantastic Corporation and COS – all of which went public during his tenure.

Dr. Matthias Oertle,

Board Member
Dr. Matthias Oertle is managing partner at Lenz & Staehelin, the leading Swiss law firm. His special expertise includes banking and capital market law, corporate finance, mergers and acquisitions, and information technology. Dr. Matthias Oertle has written numerous articles in the area of corporate law and corporate finance. He is a graduate of the University of Zurich.

Mark B. Hoffman,

Board Member 

Mr. Hoffman serves as a Director of Eightfold Logic, Inc. and ON24, Inc. From 2005 to 2007, Mr. Hoffman was President and CEO of Everdream Corp., which he sold to Dell Computer Systems in 2007. From 1996 to 2004 he was Founder, Chairman, President and CEO of Commerce One, Inc. Before that, Mr Hoffman served as Co-Founder, President, CEO and Chairman of Sybase from 1984 until 1995. Together with Dr. Bob Epstein they grew the company into the 5th largest software company at the time. Mr Hoffman holds an M.B.A. from the University of Arizona and a B.S. in Engineering from the U.S. Military Academy at West Point.

KP Doyle,

Board Member

KP Doyle is an experienced healthcare entrepreneur and financier. Mr Doyle currently is CFO of Nuffield Health, a leading UK healthcare organisation. In addition Mr Doyle sits as a non-executive director on various healthcare organisations. Mr Doyle is a Fellow of the Institute of Chartered Accountants (FCA), holds a diploma in Corporate Finance and a Bachelors degree in Economics.

Peter Ohnemus,

Vice-Chairman, Founder and CEO

Peter Ohnemus is the majority owner of dacadoo ag. Peter has been involved in high-tech and bio-tech investments over the last 25 years and this had led to four IPO’s and multiple trade sells.

Peter Ohnemus/Network Capital Holding, his private investment firm, is currently invested in high-tech, bio-tech and sustainable energy/infrastructure start-ups. The company has investments in third generation heart valves, organic search software, algorithm-based skills search exchange, real-time financial data for mobile phones, renewal energy trading platform, carbon trading, etc.

Peter co-founded ASSET4, the world’s leading provider of extra-financial information, in 2004, which was sold to Thomson Reuters in November of 2009. Mr. Ohnemus previously held senior executive positions with Sybase, Logic Works, The Fantastic Corporation and COS – all of which went public during his tenure.

Manuel Heuer,

Chief Operating Officer

Mr. Manuel Heuer combines 18 years of international business experience in the cardiovascular medical device industry and the fast moving consumer goods (FMCG) industry in Brazil, Belgium, France and Switzerland.

From 2003 to 2011, Mr. Heuer worked in various sales, business development & marketing roles with increasing management responsibilities in the cardiovascular medical device industry, first with Guidant Corporation (a Boston Scientific Company) in Belgium, France and Switzerland and then with St. Jude Medical Corporation as Managing Director of Switzerland since 2008. From 1997 to 2001, Mr. Heuer held sales and marketing positions in the FMCG industry with Nestlé in Brazil and, from 1994 to 1997, Mr. Heuer worked in marketing for an audiovisual communications company in Switzerland. Manuel Heuer holds an MBA from IMD International and speaks 5 languages fluently.